Literature DB >> 35169901

Purinergic signaling is essential for full Psickle activation by hypoxia and by normoxic acid pH in mature human sickle red cells and in vitro-differentiated cultured human sickle reticulocytes.

David H Vandorpe1,2, Alicia Rivera1,2, Markus Ganter3,4, Selasi Dankwa3,5, Jay G Wohlgemuth6, Jeffrey S Dlott6, L Michael Snyder6, Carlo Brugnara7,8, Manoj Duraisingh3, Seth L Alper9,10.   

Abstract

Paracrine ATP release by erythrocytes has been shown to regulate endothelial cell function via purinergic signaling, and this erythoid-endothelial signaling network is pathologically dysregulated in sickle cell disease. We tested the role of extracellular ATP-mediated purinergic signaling in the activation of Psickle, the mechanosensitive Ca2+-permeable cation channel of human sickle erythrocytes (SS RBC). Psickle activation increases intracellular [Ca2+] to stimulate activity of the RBC Gardos channel, KCNN4/KCa3.1, leading to cell shrinkage and accelerated deoxygenation-activated sickling.We found that hypoxic activation of Psickle recorded by cell-attached patch clamp in SS RBC is inhibited by extracellular apyrase, which hydrolyzes extracellular ATP. Hypoxic activation of Psickle was also inhibited by the pannexin-1 inhibitor, probenecid, and by the P2 antagonist, suramin. A Psickle-like activity was also activated in normoxic SS RBC (but not in control red cells) by bath pH 6.0. Acid-activated Psickle-like activity was similarly blocked by apyrase, probenecid, and suramin, as well as by the Psickle inhibitor, Grammastola spatulata mechanotoxin-4 (GsMTx-4).In vitro-differentiated cultured human sickle reticulocytes (SS cRBC), but not control cultured reticulocytes, also exhibited hypoxia-activated Psickle activity that was abrogated by GsMTx-4. Psickle-like activity in SS cRBC was similarly elicited by normoxic exposure to acid pH, and this acid-stimulated activity was nearly completely blocked by apyrase, probenecid, and suramin, as well as by GsMTx-4.Thus, hypoxia-activated and normoxic acid-activated cation channel activities are expressed in both SS RBC and SS cRBC, and both types of activation appear to be mediated or greatly amplified by autocrine or paracrine purinergic signaling.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Apyrase; Ectonucleotidase; P2 receptors; Pannexin-1; Sickle cell disease

Mesh:

Substances:

Year:  2022        PMID: 35169901     DOI: 10.1007/s00424-022-02665-z

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  52 in total

1.  Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).

Authors:  Immacolata Andolfo; Roberta Russo; Francesco Manna; Boris E Shmukler; Antonella Gambale; Giuseppina Vitiello; Gianluca De Rosa; Carlo Brugnara; Seth L Alper; L Michael Snyder; Achille Iolascon
Journal:  Am J Hematol       Date:  2015-10       Impact factor: 10.047

2.  Protonation of the human PIEZO1 ion channel stabilizes inactivation.

Authors:  Chilman Bae; Frederick Sachs; Philip A Gottlieb
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

Review 3.  Metabolomic and molecular insights into sickle cell disease and innovative therapies.

Authors:  Morayo G Adebiyi; Jeanne M Manalo; Yang Xia
Journal:  Blood Adv       Date:  2019-04-23

4.  Improvements in haemolysis and indicators of erythrocyte survival do not correlate with acute vaso-occlusive crises in patients with sickle cell disease: a phase III randomized, placebo-controlled, double-blind study of the Gardos channel blocker senicapoc (ICA-17043).

Authors:  Kenneth I Ataga; Marvin Reid; Samir K Ballas; Zahida Yasin; Carolyn Bigelow; Luther St James; Wally R Smith; Frederic Galacteros; Abdullah Kutlar; James H Hull; Jonathan W Stocker
Journal:  Br J Haematol       Date:  2011-02-17       Impact factor: 6.998

5.  In vitro genetic analysis of an erythrocyte determinant of malaria infection.

Authors:  Amy K Bei; Carlo Brugnara; Manoj T Duraisingh
Journal:  J Infect Dis       Date:  2010-10-19       Impact factor: 5.226

6.  Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia.

Authors:  G R Bergfeld; T Forrester
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

7.  In vitro inhibition of human UGT isoforms by ritonavir and cobicistat.

Authors:  Sara Algeelani; Novera Alam; Md Amin Hossain; Gerd Mikus; David J Greenblatt
Journal:  Xenobiotica       Date:  2017-09-11       Impact factor: 1.908

Review 8.  Gene therapy for sickle cell disease: moving from the bench to the bedside.

Authors:  Allistair A Abraham; John F Tisdale
Journal:  Blood       Date:  2021-09-16       Impact factor: 25.476

9.  The Effect of Antioxidants on the Properties of Red Blood Cells From Patients With Sickle Cell Anemia.

Authors:  Halima Al Balushi; Anke Hannemann; David Rees; John Brewin; John Stanley Gibson
Journal:  Front Physiol       Date:  2019-08-13       Impact factor: 4.566

10.  The TRPV2 channel mediates Ca2+ influx and the Δ9-THC-dependent decrease in osmotic fragility in red blood cells.

Authors:  Anouar Belkacemi; Claudia Fecher Trost; René Tinschert; Daniel Flormann; Mahsa Malihpour; Christian Wagner; Markus R Meyer; Andreas Beck; Veit Flockerzi
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.